ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia

This study is currently recruiting participants.
Verified by National Institute of Mental Health (NIMH), May 2008

Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier: NCT00247637
  Purpose

This is a study of the genetic basis of brain dysfunction in people with schizophrenia.


Condition
Schizophrenia

MedlinePlus related topics:   Mental Health   Schizophrenia  

U.S. FDA Resources

Study Type:   Observational
Study Design:   Prospective
Official Title:   The Genetics of Endophenotypes and Schizophrenia

Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment:   1680
Study Start Date:   May 2003
Estimated Study Completion Date:   May 2008

Detailed Description:

Schizophrenia is a disabling disorder that is associated with specific inheritable neurobiologic deficits. These deficits can cause problems with memory, visual attention, information processing, and other aspects of daily living. Understanding the genetic components of these deficits in people with schizophrenia and their unaffected family members may help uncover the neurobiological basis, risk factors, and heritability of the disease. In addition, the information may serve to create more effective treatments and possibly a cure for the disease. This study will serve to provide information about the genetic basis of known inherited neurobiological deficits in people with schizophrenia. In turn, this may guide further studies on the genetics of schizophrenia.

Participants will attend 2 study visits, each of which will last approximately 4 hours. The first will include blood tests and diagnostic interviews of participating families to evaluate the presence of schizophrenic symptoms. The second study visit will entail four neurocognitive and neurophysiological tests. Participants will first have a pre-pulse inhibition test, which uses electrodes to measure eye blinking. Electrodes will also be placed on participants' head, ears, and around their eyes to measure brain waves. Next, participants will undergo an oculomotor test, during which they will wear glasses fitted with sensors that record eye movement. Participants will then be asked to repeat a list of words, letters, and numbers read by a researcher. Last, participants will undergo a computerized performance test requiring them to watch the computer screen and click a mouse whenever they see a number between 0 and 9. Each study visit will take approximately 4 hours.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria for Participating Families:

  • Families with at least one member who has schizophrenia

Exclusion Criteria:

  • N/A
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00247637

Contacts
Contact: Andras A. Kovach, BS     866-359-2496     akovach@ucsd.edu    

Locations
United States, California
University of California, San Diego     Recruiting
      San Diego, California, United States, 92103
      Contact: Barbara Haugeland, PhD     619-543-7201     bhaugeland@ucsd.edu    
      Principal Investigator: David Braff, MD            
University of California Los Angeles     Recruiting
      Los Angeles, California, United States, 90073
      Contact: Karen Cornelius, PsyD     310-478-3711 ext 43929     karen.cornelius@med.va.gov    
      Principal Investigator: Michael Green, PhD            
United States, Colorado
University of Colorado Health Sciences Center     Recruiting
      Denver, Colorado, United States, 80220
      Contact: Chris Cason, BS     303-807-7382     chris.cason@uchsc.edu    
      Principal Investigator: Ann Olincy, MD            
United States, Massachusetts
Harvard University     Recruiting
      Boston, Massachusetts, United States, 02115
      Contact: Monica Landi, MSW     617-998-5015     cogs@bidmc.harvard.edu    
      Principal Investigator: Larry Seidman, PhD            
United States, New York
Mount Sinai School of Medicine     Recruiting
      New York, New York, United States, 10029
      Contact: Robert Fieo, MA     212-659-5625     robert.fieo@mssm.edu    
      Principal Investigator: Larry Siever, MD            
United States, Pennsylvania
University of Pennsylvania     Recruiting
      Philadelphia, Pennsylvania, United States, 19104
      Contact: Raquel E. Gur, MD, PhD     888-635-7780     cogs@bbl.med.upenn.edu    
      Contact: Caryn Hussar     888-635-7780     cogs@bbl.med.upenn.edu    
      Principal Investigator: Raquel E. Gur, MD, PhD            
United States, Washington
University of Washington and VA Puget Sound Health Care System     Recruiting
      Seattle, Washington, United States, 98108
      Contact: Denise Pritzl, LCSW     800-597-5441     seacogs@u.washington.edu    
      Principal Investigator: Debby Tsuang, MD, MPH            

Sponsors and Collaborators

Investigators
Study Director:     David Braff, MD     University of California, San Diego    
  More Information

Click here for more information on the Schizophrenia Research Program  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   R01 MH65571, R01 MH65707, R01 MH65578, R01 MH65588, R01 MH65554, R01 MH65562, DNBBS 7G-GRR
First Received:   October 31, 2005
Last Updated:   May 19, 2008
ClinicalTrials.gov Identifier:   NCT00247637
Health Authority:   United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):
Mental Health  
Psychosis  
Genetics  
Heredity  

Study placed in the following topic categories:
Schizophrenia
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

Additional relevant MeSH terms:
Mental Disorders

ClinicalTrials.gov processed this record on July 03, 2008




Links to all studies - primarily for crawlers